Peder Charles , Leif Mosekilde , Leila Risteli , Juha Risteli , Erik Fink Eriksen
{"title":"Assessment of bone remodeling using biochemical indicators of type I collagen synthesis and degradation: relation to calcium kinetics","authors":"Peder Charles , Leif Mosekilde , Leila Risteli , Juha Risteli , Erik Fink Eriksen","doi":"10.1016/S0169-6009(08)80147-X","DOIUrl":null,"url":null,"abstract":"<div><p>In this study, we investigated the relation between calcium kinetic indices of bone remodeling (resorption rate, <em>r</em>; and formation rate, <em>m</em>, respectively) and two serum markers of type I collagen turnover: the pyridinoline cross-linked carboxyterminal telopeptide domains of type I collagen (<em>S</em>-ICTP a marker of bone matrix degradation) and the carboxyterminal propeptide of human type I procollagen (<em>S</em>-PICP, a marker of bone matrix formation). We studied three groups: (i) healthy controls (<em>n</em> = 19), (ii) a mixed group of high and low-turnover bone diseases without mineralization defects (myxedema, thyrotoxicosis and primary hyperparathyroidism <em>n</em> = 38), and (iii) osteoporosis (<em>n</em> = 52). In healthy controls, a significant regression of <em>S</em>-PICP on <em>m</em> was obtained (<em>R</em> = 0.53, SEE/Y = 0.44, <em>P</em> < 0.02). Significant regressions were also demonstrable in high- and low-turnover bone disease (<em>R</em> = 0.50, <em>P</em> < 0.001), SEE/Y = 61%) and osteoporosis (<em>R</em> = 0.49, <em>P</em> < 0.001, SEE/Y = 50%). In controls the regression coefficient for the regression of <em>S</em>-ICTP on <em>r</em> was 0.19 (NS), in high and low turnover bone disease 0.66, (SEE/Y = 59%, <em>P</em> < 0.001) and in the osteoporotic group 0.40 (SEE/Y = 61%, <em>P</em> < 0.01). We conclude that <em>S</em>-PICP and <em>S</em>-ICTP reflect whole skeletal bone formation and resorption rates in a variety of metabolic bone diseases including osteoporosis.</p></div>","PeriodicalId":77047,"journal":{"name":"Bone and mineral","volume":"24 2","pages":"Pages 81-94"},"PeriodicalIF":0.0000,"publicationDate":"1994-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0169-6009(08)80147-X","citationCount":"116","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bone and mineral","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S016960090880147X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 116
Abstract
In this study, we investigated the relation between calcium kinetic indices of bone remodeling (resorption rate, r; and formation rate, m, respectively) and two serum markers of type I collagen turnover: the pyridinoline cross-linked carboxyterminal telopeptide domains of type I collagen (S-ICTP a marker of bone matrix degradation) and the carboxyterminal propeptide of human type I procollagen (S-PICP, a marker of bone matrix formation). We studied three groups: (i) healthy controls (n = 19), (ii) a mixed group of high and low-turnover bone diseases without mineralization defects (myxedema, thyrotoxicosis and primary hyperparathyroidism n = 38), and (iii) osteoporosis (n = 52). In healthy controls, a significant regression of S-PICP on m was obtained (R = 0.53, SEE/Y = 0.44, P < 0.02). Significant regressions were also demonstrable in high- and low-turnover bone disease (R = 0.50, P < 0.001), SEE/Y = 61%) and osteoporosis (R = 0.49, P < 0.001, SEE/Y = 50%). In controls the regression coefficient for the regression of S-ICTP on r was 0.19 (NS), in high and low turnover bone disease 0.66, (SEE/Y = 59%, P < 0.001) and in the osteoporotic group 0.40 (SEE/Y = 61%, P < 0.01). We conclude that S-PICP and S-ICTP reflect whole skeletal bone formation and resorption rates in a variety of metabolic bone diseases including osteoporosis.